Levosimendan in the light of the results of the recent randomized controlled trials: an expert opinion paper

Despite interesting and unique pharmacological properties, levosimendan has not proven a clear superiority to placebo in the patient populations that have been enrolled in the various recent multicenter random...

Source: Critical Care - November 29, 2019 Category: Intensive Care Authors: Bernard Cholley, Bruno Levy, Jean-Luc Fellahi, Dan Longrois, Julien Amour, Alexandre Ouattara and Alexandre Mebazaa Tags: Review Source Type: research